This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
Discussing Agios’ Mitapivat in Sickle Cell Disease (Oral PK Activator) after its Phase 3 Readout
Ticker(s): AGIOWho's the expert?
Institution: Emory University
- Associate professor of pediatrics at Emory University
- Currently manages ~150 patients with Sickle Cell Disease
- Research focuses on the mechanisms of globin switching and the pharmacogenomics of hydroxyurea in SCD
Interview GoalTo gain a deeper understanding of Mitapivat as a potential treatment for sickle cell disease
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
